Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 2 5Phase 3 2Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

pembrolizumab 109Paclitaxel 65Cyclophosphamide 65Cisplatin 60Carboplatin 56Gemcitabine 48Radiotherapy 45Nivolumab 43fludarabine 38Docetaxel 38Pemetrexed 33Dexamethasone 32Capecitabine 32Lenalidomide 26fludarabine phosphate 25Rituximab 25Radiation 25Ipilimumab 25Doxorubicin 25Irinotecan 24Bevacizumab 24Azacitidine 24Vorinostat 23Vincristine 22Cytarabine 22Temozolomide 20Etoposide 20Oxaliplatin 19Fluorouracil 19atezolizumab 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Has results × Exercise × Clear all
NCT02006979 2019-10-25

Acute Exercise Cardioprotection From Doxorubicin

University of British Columbia

Phase 1 Completed
27 enrolled 18 charts
Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡